title: Recommendations for specimen collection for NBOMe analysis in clinical toxicology.
authors.affiliation: a Department of Pharmacology & Toxicology , Virginia Commonwealth University , Richmond , VA , USA.
authors.forename: Justin L
authors.initials: JL
authors.lastname: Poklis
authors.affiliation: b Department of Pathology , Virginia Commonwealth University , Richmond , VA , USA.|c Department of Forensic Science , Virginia Commonwealth University , Richmond , VA , USA.
authors.forename: Carl E
authors.initials: CE
authors.lastname: Wolf
authors.affiliation: b Department of Pathology , Virginia Commonwealth University , Richmond , VA , USA.
authors.forename: Carrol R
authors.initials: CR
authors.lastname: Nanco
authors.affiliation: a Department of Pharmacology & Toxicology , Virginia Commonwealth University , Richmond , VA , USA.|b Department of Pathology , Virginia Commonwealth University , Richmond , VA , USA.|c Department of Forensic Science , Virginia Commonwealth University , Richmond , VA , USA.
authors.forename: Alphonse
authors.initials: A
authors.lastname: Poklis
mesh_terms: D015415:Biomarkers / Q000652:urine; D015198:Designer Drugs / Q000633:toxicity; D004118:Dimethoxyphenylethylamine / Q000633:toxicity* / Q000652:urine; D004353:Drug Evaluation, Preclinical; D005021:Ethylamines / Q000633:toxicity*; D006213:Hallucinogens / Q000633:toxicity* / Q000652:urine; D006801:Humans; D011634:Public Health; D013048:Specimen Handling; D018675:Toxicity Tests
chemical_list: D015415:Biomarkers; D015198:Designer Drugs; D004118:Dimethoxyphenylethylamine; D005021:Ethylamines; D006213:Hallucinogens